abstract
- Mounting evidence suggests that insulin therapy may reduce risk for CV events while preserving beta-cell function, and several continuing long-term CV trials are testing these hypotheses explicitly.
Insulin Therapy in People Who Have Dysglycemia and Type 2 Diabetes Mellitus: Can It Offer Both Cardiovascular Protection and Beta-Cell Preservation?
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
authors
status
publication date
- March 2005
has subject area
- 1103 Clinical Sciences (FoR)
- 1114 Paediatrics and Reproductive Medicine (FoR)
- Cardiovascular Diseases (MeSH)
- Clinical Trials as Topic (MeSH)
- Diabetes Mellitus, Type 2 (MeSH)
- Endocrinology & Metabolism (Science Metrix)
- Humans (MeSH)
- Hyperglycemia (MeSH)
- Insulin (MeSH)
- Islets of Langerhans (MeSH)